SEC filings
Labcorp (LH)
Recent filings Labcorp made with the SEC, newest first. Most have a short AI-generated summary, and every one links to the original.
CIK 0000920148All filings on SEC.gov
8-KCurrent report
Regulation FD Disclosure
Labcorp Holdings Inc. announced that Chief Financial Officer Julia Wang will speak at the UBS Global Healthcare Conference on November 10, 2026, in a fireside chat webcast from the company's investor relations site. …
10-QQuarterly report
Quarterly report
Labcorp's quarterly report on Form 10-Q, filed on 2026-10-30, includes forward-looking statements about its operations, performance, financial condition, and strategic objectives and lists related risk factors.
8-KCurrent report
Results of Operations and Financial Condition
Labcorp reported third-quarter 2026 revenue of $3.81 billion, up 6.9%, and adjusted EPS of $4.78, up 14.5%, and raised its full-year 2026 revenue growth and adjusted EPS guidance. …
8-KCurrent report
Regulation FD Disclosure
Labcorp Holdings Inc. (NYSE: LH) declared a quarterly cash dividend of $0.72 per share of common stock, payable December 11, 2026 to stockholders of record as of the close of business on November 24, 2026.
8-KCurrent report
Regulation FD Disclosure
Labcorp Holdings (NYSE: LH) will release its third-quarter 2026 financial results before the market opens on October 28, 2026, and will host a webcast at 9:00 a.m. ET that day to discuss them.
8-KCurrent report
Regulation FD Disclosure
CMS released preliminary Clinical Laboratory Fee Schedule payment rates for 2027 through 2029 under PAMA, which Labcorp said are based on data not fully representative of the broader commercial laboratory market and would impose steep…
8-KCurrent report
Regulation FD Disclosure
Labcorp hosted its 2026 Investor Day, reaffirmed full-year 2026 guidance, and provided a long-term outlook through 2029 with compound annual revenue growth of 5% to 8% and compound annual adjusted EPS growth of 8.5% to 11.5%. …
8-KCurrent report
Regulation FD Disclosure
Labcorp Holdings (NYSE: LH) said members of its executive management team will participate in a fireside chat at the Morgan Stanley 24th Annual Global Healthcare Conference on Sept. 15, 2026, at 11:30 a.m. ET.
8-KCurrent report
Regulation FD Disclosure
Labcorp Holdings Inc. (NYSE: LH) will host an Investor Day on September 10, 2026, where Chairman and CEO Adam Schechter, Executive Vice President and CFO Julia Wang, and other executives will discuss the company's go-forward strategy…
8-KCurrent report
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Labcorp Holdings Inc. executive Megan D. Bailey will resign as Executive Vice President and President, Central Laboratories and International effective September 4, 2026, while Brian J. …
10-QQuarterly report
Quarterly report
Labcorp filed its quarterly Form 10-Q report, whose management's discussion and analysis sets out forward-looking statements on the company's operations, financial condition, and strategic objectives. …
8-KCurrent report
Results of Operations and Financial Condition
Labcorp reported second-quarter 2026 revenue of $3.73 billion, up 5.8% from a year earlier, with diluted EPS of $3.64 and adjusted EPS of $4.99, up 14.9%, and raised its full-year 2026 revenue growth and adjusted EPS guidance. …
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.
Follow Labcorp in Readster
Add Labcorp to your watchlist and its SEC filings reach your brief alongside the news about it, every line cited to its source. Readster also follows topics, people, newsletters and podcasts.
No credit card. When the trial ends, you move to Readster Free unless you subscribe.